pre-miRNA Information
pre-miRNA hsa-mir-4281   
Genomic Coordinates chr5: 176629439 - 176629500
Description Homo sapiens miR-4281 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-4281
Sequence 35| GGGUCCCGGGGAGGGGGG |52
Evidence Experimental
Experiments SOLiD
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs921488943 1 dbSNP
rs1040286402 3 dbSNP
rs1375541904 8 dbSNP
rs759166911 12 dbSNP
rs768735686 13 dbSNP
rs746495416 14 dbSNP
rs779751131 18 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol SLC29A2   
Synonyms DER12, ENT2, HNP36
Description solute carrier family 29 member 2
Transcript NM_001532   
Expression
Putative miRNA Targets on SLC29A2
3'UTR of SLC29A2
(miRNA target sites are highlighted)
>SLC29A2|NM_001532|3'UTR
   1 AGTGGCCCCTCCAGGCTCTTTGGCAGCCTCTTCTCGACGTCTCCTTCCGGAGCTGAGATCCAGCCCAGGGCGAATGGCGA
  81 GCTTGGCTCAGGCCTCTGCGGGGTGGAGGCCCCTGGGCCTGAGGCTGCCAGCAGCGGGCAGGAGCTGCTCTTCATCCACT
 161 TGGAGTGCTGCGGGGAAGAAATCACCACCGGTCATTCTAACCCTCACCCAGGAATGGGGGTGACTCGCACAAGACCTCAT
 241 GGAAAGGGTGATGACTAGGGAAAAGAGGGTGCAGGGCACGGCTGCTCCCCACCACCAGGTCTGCATTTGTTCATCATCAT
 321 CAGGAGCAGAGGTGACCAGAGGGTTCAGAGTGGGAGGCGGGGCCAGCCCAGGCCAGGAGCGCCTCATCTTCCCAGGCCTC
 401 AGCCACCCAGGGTAAAAGGTGCCAGGGAAGTTGTGGGCACCTGAGAGGAGGAACAGATGTGGAGGACCTGAGGGTGCTCA
 481 AAGGGCCAGGCTCAGCCTCAAGCAGTGTTTTCATTGCCAACACTTACTGTACCCACTCCGCAGAGCCCAGCTGGGCCTGG
 561 GCCCCAGGGCCACAGCTAGCCTGCATGTGTGTACTGCACTTTACAGTTTGCAAAGCTCTTCCATACCCACTCTCTCACCG
 641 AAGCCTAATTGAGGCTCTTGGAAGGAGTCAGGCAAGGATTGTGCTTCCCCCATTATACAGGTGACAAAACTGAGTCCTGG
 721 GGAAAGTGACTGGTCCGTGGTAGAGCCGGGACCCAATCCCCTCTCTCTCCTCCCTGTTGGTGCTGTTCTTCCTGCCCAAC
 801 ACCTGTTTCTCTTTTCCTCAAGGGGTTTGGGGCAGGAGCCTGGGCACTTACTCCCCGTTTTTGCTGTTTCTCCTTCTGAC
 881 CCTGCTCTTGGGTCTAATAACCCCATTTATTTGTAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ggggggaggGGCCCUGGg 5'
                   |||||||| 
Target 5' gtggtagagCCGGGACCc 3'
737 - 754 145.00 -21.30
2
miRNA  3' ggggggagggGCCCUGGg 5'
                    ||||:|| 
Target 5' gagtgggaggCGGGGCCa 3'
348 - 365 124.00 -14.50
3
miRNA  3' ggggGGA---GGGGCCCUGGg 5'
              |||   |||| ||:|| 
Target 5' tgggCCTGGGCCCCAGGGCCa 3'
552 - 572 110.00 -20.90
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSM7696915 43 COSMIC
COSM9042241 57 COSMIC
COSM4879745 60 COSMIC
COSM4388211 78 COSMIC
COSM5964850 81 COSMIC
COSM7683009 100 COSMIC
COSM5795555 121 COSMIC
COSM8852776 139 COSMIC
COSN30118891 166 COSMIC
COSN21444999 175 COSMIC
COSN17211194 226 COSMIC
COSN25883577 446 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs370779067 2 dbSNP
rs928631275 4 dbSNP
rs747922084 5 dbSNP
rs778565211 9 dbSNP
rs924262810 16 dbSNP
rs1186086559 20 dbSNP
rs755003887 21 dbSNP
rs368983834 23 dbSNP
rs767723880 24 dbSNP
rs978426731 25 dbSNP
rs757371498 26 dbSNP
rs751835374 28 dbSNP
rs372203488 35 dbSNP
rs763071257 36 dbSNP
rs753174515 37 dbSNP
rs765488621 38 dbSNP
rs760087374 39 dbSNP
rs777075996 41 dbSNP
rs542692645 48 dbSNP
rs778278574 49 dbSNP
rs749057932 52 dbSNP
rs1459779376 54 dbSNP
rs1350760441 55 dbSNP
rs771818227 56 dbSNP
rs117647993 60 dbSNP
rs778813133 61 dbSNP
rs1189263324 64 dbSNP
rs985906683 66 dbSNP
rs768519192 67 dbSNP
rs749265652 69 dbSNP
rs1257933358 70 dbSNP
rs757424477 71 dbSNP
rs751717997 72 dbSNP
rs1250967553 75 dbSNP
rs777709785 78 dbSNP
rs1339612067 79 dbSNP
rs1276279866 81 dbSNP
rs957550178 88 dbSNP
rs756257806 92 dbSNP
rs1428563507 95 dbSNP
rs553941215 99 dbSNP
rs1389027885 100 dbSNP
rs750725427 102 dbSNP
rs1297940672 108 dbSNP
rs905198957 109 dbSNP
rs765658414 110 dbSNP
rs1372675232 118 dbSNP
rs1045524341 123 dbSNP
rs34124904 125 dbSNP
rs781235865 130 dbSNP
rs540571414 135 dbSNP
rs754349659 136 dbSNP
rs1375935667 137 dbSNP
rs753553661 138 dbSNP
rs1434826154 155 dbSNP
rs1255862298 160 dbSNP
rs578164529 161 dbSNP
rs1267861263 167 dbSNP
rs1181156584 168 dbSNP
rs1039593 171 dbSNP
rs187031975 172 dbSNP
rs761160778 173 dbSNP
rs1252156676 174 dbSNP
rs569527921 174 dbSNP
rs1253726043 175 dbSNP
rs766217878 176 dbSNP
rs771455971 178 dbSNP
rs1220014440 180 dbSNP
rs761547262 181 dbSNP
rs1313265635 183 dbSNP
rs1192360019 184 dbSNP
rs183221431 189 dbSNP
rs112593209 190 dbSNP
rs1170675957 191 dbSNP
rs1352655944 197 dbSNP
rs1308871572 201 dbSNP
rs567515154 203 dbSNP
rs1290419170 208 dbSNP
rs1162079549 209 dbSNP
rs1365430165 210 dbSNP
rs1005322331 218 dbSNP
rs1295862906 226 dbSNP
rs553637970 240 dbSNP
rs34186490 243 dbSNP
rs986260570 243 dbSNP
rs1367646867 246 dbSNP
rs1318197074 260 dbSNP
rs527600383 267 dbSNP
rs148959185 279 dbSNP
rs551508946 280 dbSNP
rs1345938331 290 dbSNP
rs1223652087 293 dbSNP
rs1258938991 305 dbSNP
rs74834302 311 dbSNP
rs1403030425 312 dbSNP
rs562614637 323 dbSNP
rs906452525 325 dbSNP
rs536523852 337 dbSNP
rs946070470 340 dbSNP
rs913302635 342 dbSNP
rs1167490768 343 dbSNP
rs1343473056 344 dbSNP
rs1047029 359 dbSNP
rs879308756 361 dbSNP
rs1470396007 365 dbSNP
rs1391020580 379 dbSNP
rs3741366 380 dbSNP
rs1314696738 381 dbSNP
rs1379592736 391 dbSNP
rs1229857524 394 dbSNP
rs1174662891 397 dbSNP
rs905167514 406 dbSNP
rs529299355 408 dbSNP
rs560320262 410 dbSNP
rs1316287254 411 dbSNP
rs911369160 420 dbSNP
rs1215802803 421 dbSNP
rs367972776 422 dbSNP
rs201724518 425 dbSNP
rs1263134007 426 dbSNP
rs11227466 427 dbSNP
rs116864252 430 dbSNP
rs1014069119 440 dbSNP
rs751350402 447 dbSNP
rs1486590262 449 dbSNP
rs922877254 449 dbSNP
rs896598337 454 dbSNP
rs761438578 458 dbSNP
rs1419008233 468 dbSNP
rs889683314 474 dbSNP
rs1414255374 483 dbSNP
rs1468340011 484 dbSNP
rs1379603838 495 dbSNP
rs961051346 498 dbSNP
rs903032186 499 dbSNP
rs1359993134 504 dbSNP
rs1449890145 520 dbSNP
rs1264783327 522 dbSNP
rs1221520704 529 dbSNP
rs764137872 533 dbSNP
rs1372437627 534 dbSNP
rs1228919408 538 dbSNP
rs537860035 539 dbSNP
rs192877986 540 dbSNP
rs947324633 541 dbSNP
rs1216230642 543 dbSNP
rs879298207 548 dbSNP
rs3177514 549 dbSNP
rs556194094 550 dbSNP
rs116183086 555 dbSNP
rs933055067 556 dbSNP
rs567330411 559 dbSNP
rs1003823041 564 dbSNP
rs1254639837 570 dbSNP
rs753102720 571 dbSNP
rs971808403 584 dbSNP
rs1334967433 591 dbSNP
rs962172163 596 dbSNP
rs1469650364 606 dbSNP
rs145780180 610 dbSNP
rs1353687253 616 dbSNP
rs985019875 626 dbSNP
rs1309732698 627 dbSNP
rs1343589459 632 dbSNP
rs1274930728 637 dbSNP
rs969692434 637 dbSNP
rs1024044695 639 dbSNP
rs1427219480 640 dbSNP
rs1010229948 643 dbSNP
rs1187320981 649 dbSNP
rs891773471 668 dbSNP
rs1461367215 669 dbSNP
rs1206349758 674 dbSNP
rs149792941 686 dbSNP
rs936031146 687 dbSNP
rs570066211 690 dbSNP
rs1199416709 693 dbSNP
rs1482830751 695 dbSNP
rs1247353766 696 dbSNP
rs1479076958 713 dbSNP
rs1251620573 727 dbSNP
rs961074068 728 dbSNP
rs1229555891 731 dbSNP
rs1049915233 733 dbSNP
rs1430113725 736 dbSNP
rs188481560 737 dbSNP
rs749286699 745 dbSNP
rs1423922762 746 dbSNP
rs922858941 747 dbSNP
rs1428085505 748 dbSNP
rs756859035 748 dbSNP
rs972987223 756 dbSNP
rs551853990 757 dbSNP
rs902999760 759 dbSNP
rs1042894633 760 dbSNP
rs909514737 765 dbSNP
rs1209744713 768 dbSNP
rs1452127580 770 dbSNP
rs983761635 776 dbSNP
rs532108020 794 dbSNP
rs1300195814 800 dbSNP
rs1241685250 801 dbSNP
rs959147456 814 dbSNP
rs1460931969 827 dbSNP
rs183547244 830 dbSNP
rs1190824042 839 dbSNP
rs1383139311 842 dbSNP
rs932960585 844 dbSNP
rs1164766736 845 dbSNP
rs922939269 853 dbSNP
rs1003359845 856 dbSNP
rs746022505 857 dbSNP
rs537742544 878 dbSNP
rs940442138 885 dbSNP
rs1386531484 891 dbSNP
rs759717168 896 dbSNP
rs1381000966 902 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ggGGGGAGGG---GCCCUGGg 5'
            |:||||||   :|| :|: 
Target 5' cuCUCCUCCCUGUUGGUGCUg 3'
15 - 35
2
miRNA  3' ggggggaggggcccUGGg 5'
                        ||| 
Target 5' --------------ACCc 3'
1 - 4
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000311161.7 | 3UTR | ACCCAAUCCCCUCUCUCUCCUCCCUGUUGGUGCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
29 hsa-miR-4281 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT218864 CDKN1A cyclin dependent kinase inhibitor 1A 2 4
MIRT248841 SESN2 sestrin 2 2 2
MIRT452803 PACS2 phosphofurin acidic cluster sorting protein 2 2 2
MIRT462825 BCL3 B-cell CLL/lymphoma 3 2 2
MIRT467812 SLC29A2 solute carrier family 29 member 2 2 2
MIRT477707 EFHD2 EF-hand domain family member D2 2 2
MIRT490047 PRRT2 proline rich transmembrane protein 2 2 2
MIRT491813 ZBTB7B zinc finger and BTB domain containing 7B 2 2
MIRT528905 THBS2 thrombospondin 2 2 2
MIRT534124 SNX33 sorting nexin 33 2 2
MIRT550881 IBA57 IBA57 homolog, iron-sulfur cluster assembly 2 2
MIRT551263 PSMG1 proteasome assembly chaperone 1 2 2
MIRT551984 UGT2B10 UDP glucuronosyltransferase family 2 member B10 2 2
MIRT608916 NCDN neurochondrin 2 6
MIRT637226 TMEM59 transmembrane protein 59 2 2
MIRT644445 ALDOC aldolase, fructose-bisphosphate C 2 2
MIRT657162 IP6K1 inositol hexakisphosphate kinase 1 2 2
MIRT658754 ELAVL3 ELAV like RNA binding protein 3 2 2
MIRT668304 FOSL2 FOS like 2, AP-1 transcription factor subunit 2 2
MIRT687548 MLEC malectin 2 2
MIRT690860 PLEKHG2 pleckstrin homology and RhoGEF domain containing G2 2 2
MIRT697063 PSMC4 proteasome 26S subunit, ATPase 4 2 2
MIRT700860 PER2 period circadian clock 2 2 2
MIRT705073 C4orf29 abhydrolase domain containing 18 2 2
MIRT713930 PIGR polymeric immunoglobulin receptor 2 2
MIRT715904 MFRP membrane frizzled-related protein 2 2
MIRT716060 SFTPB surfactant protein B 2 2
MIRT716729 APOL6 apolipoprotein L6 2 2
MIRT723382 NFAM1 NFAT activating protein with ITAM motif 1 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-4 Dexamethasone approved 5743 Microarray primary rat thymocytes 20847043 2010 up-regulated
miR-4281 Ginsenoside Rh2 NULL 119307 Microarray NSCLC cell line A549 23152132 2013 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-4281 Cisplatin 5460033 NSC119875 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-4281 Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-4281 Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (PLX4032, LM16)
hsa-miR-4281 Cisplatin 5460033 NSC119875 approved resistant High Pancreatic Cancer cell line (BxPC-3)
hsa-miR-4281 Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (A375)
hsa-miR-4281 Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-4281 Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (H460)
hsa-mir-4281 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-4281 Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-mir-4281 Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-mir-4281 Doxorubicin 31703 NSC123127 approved resistant cell line (HS578T)
hsa-mir-4281 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-4281 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-4281 Cisplatin 5460033 NSC119875 approved resistant cell line (BxPC3)
hsa-miR-4281 Temozolomide 5394 NSC362856 approved resistant cell line (U251)
hsa-miR-4281 Tamoxifen+Fulvestrant resistant cell line (LCC9)
hsa-miR-4281 Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-4281 Cisplatin 5460033 NSC119875 approved resistant cell line (CP20)
hsa-miR-4281 Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-4281 Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-4281 Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM16)
hsa-miR-4281 Neoadjuvant chemotherapy sensitive tissue (breast cancer)
hsa-miR-4281 Cisplatin 5460033 NSC119875 approved sensitive cell line (TOV-112D)
hsa-miR-4281 Cisplatin 5460033 NSC119875 approved resistant cell line (OVSAHO)

Error report submission